Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study
Author:
Funder
Office of Naval Research
NCI
HRSA
Publisher
Elsevier BV
Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference49 articles.
1. "No donor"? Consider a haploidentical transplant;Ciurea;Blood Rev,2015
2. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings;Szydlo;J Clin Oncol,1997
3. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide;Luznik;Blood,2001
4. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia;Ciurea;Blood,2015
5. Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation;Al Malki;Blood Adv,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation;Frontiers in Immunology;2024-03-27
2. New development of HLA research in allogeneic hematopoietic cell transplantation;Japanese Journal of Transplantation and Cellular Therapy;2024
3. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome;Transplantation and Cellular Therapy;2023-10
4. Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy;Transplantation and Cellular Therapy;2023-06
5. Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy;Frontiers in Immunology;2022-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3